relcovaptan has been researched along with Muscle Contraction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christophe, B; Garcia, C; Guiraudou, P; Lacour, C; Le Fur, G; Maffrand, JP; Nisato, D; Serradeil-Le Gal, C; Villanova, G; Wagnon, J | 1 |
| Burrell, LM; Buxton, BB; Chen, JR; Johnston, CI; Liu, JJ | 1 |
| Saxena, PR; Stam, WB; Van der Graaf, PH | 1 |
3 other study(ies) available for relcovaptan and Muscle Contraction
| Article | Year |
|---|---|
Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.
Topics: Animals; Arginine Vasopressin; Cattle; Cell Membrane; Humans; In Vitro Techniques; Indoles; Muscle Contraction; Piperidines; Platelet Aggregation; Pyrrolidines; Quinolones; Rats; Receptors, Vasopressin | 1993 |
Potent inhibitory effect of SR 49059, an orally active non-peptide vasopressin VIa receptor antagonist, on human arterial coronary bypass graft.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Arteries; Hormone Antagonists; Humans; Indoles; Mammary Arteries; Muscle Contraction; Pyrrolidines | 1995 |
Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aorta; Arginine Vasopressin; Dose-Response Relationship, Drug; Hormone Antagonists; In Vitro Techniques; Indoles; Male; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Piperidines; Pyrrolidines; Quinolones; Rats; Rats, Wistar; Receptors, Oxytocin; Receptors, Vasopressin; Vasotocin | 1998 |